Medtronic Plc (MDT)

105.52
1.00 0.99
NYSE : Health Technology
Prev Close 104.49
Open 105.38
Day Low/High 104.81 / 106.07
52 Wk Low/High 81.66 / 112.05
Volume 1.85M
Avg Volume 4.37M
Exchange NYSE
Shares Outstanding 1.34B
Market Cap 145.06B
EPS 3.40
P/E Ratio 32.86
Div & Yield 2.16 (1.92%)
U.S. Eases Sanctions on Russian Intelligence Agency, Making Life Easier for Tech Exporters

U.S. Eases Sanctions on Russian Intelligence Agency, Making Life Easier for Tech Exporters

The Treasury Department's move to ease sanctions on Russian intelligence agency FSB was good news for Russia ETFs -- and U.S. exporters.

Honeywell and 4 More Stock Charts to Watch

Honeywell and 4 More Stock Charts to Watch

Here's how to use charts to trade five stocks, including Dow Chemical and Honeywell.

Dow Chemical, Honeywell, Medtronic Not Done Rallying

Dow Chemical, Honeywell, Medtronic Not Done Rallying

Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)

Earnings Key to Next Week's Winners: Cramer's 'Mad Money' Recap (Friday 1/13/17)

Jim Cramer highlights bank, health-care companies reporting next week and what to watch.

3 Rising Dividend Stocks Right on Target for 2017

3 Rising Dividend Stocks Right on Target for 2017

Dividend growers Texas Instruments, Accenture and Medtronic are superior to companies that simply sport high dividend yields, says one portfolio manager.

What Exactly Are Investors Missing Out On?

Statistically, Friday's rally was not the best one.

3 Health Care Giants Set to Ride Out Washington's Sound and Fury

3 Health Care Giants Set to Ride Out Washington's Sound and Fury

An attempt to repeal the Affordable Care Act and the brewing policy war between President-elect Donald Trump and the Democrats won't slow these three health sector juggernauts.

'Mad Money' Lightning Round: Jim Cramer Sees Opportunity in Sirius and Medtronic

'Mad Money' Lightning Round: Jim Cramer Sees Opportunity in Sirius and Medtronic

Sirius, Medtronic and Carlyle could be money makers in 2017, says Jim Cramer.

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Cramer's 'Mad Money' Recap (Tuesday 1/3/17): Better Buying Opportunities Are Lurking

Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.

Don't Be So Quick to Be Bullish

The ETF put/call ratio chart indicates some limited upside.

5 Blue-Chip Breakout Trades to Ring in the New Year

5 Blue-Chip Breakout Trades to Ring in the New Year

While most investors fixate on Dow 20,000, breakouts are already happening in the individual stocks.

Top 10 Dividend Stocks You Need to Buy Now to Prepare for 2017

Top 10 Dividend Stocks You Need to Buy Now to Prepare for 2017

Here's a look at the 10 best dividend stocks to invest in for potential outperformance in 2017.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies -- including Medtronic and Medicines -- have been scooping up shares of their own stock lately.

How to Compute a Higher IBM Price: It's Elementary, Watson

How to Compute a Higher IBM Price: It's Elementary, Watson

Just like cloud computing drove Amazon, AI should do the same for Big Blue.

Edwards' Life Goes On Without Big M&A

Edwards' Life Goes On Without Big M&A

As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.

Broadcom Call Should 'Make You Feel Better About Owning Apple': More Squawk From Jim Cramer

Broadcom Call Should 'Make You Feel Better About Owning Apple': More Squawk From Jim Cramer

Broadcom released better-than-expected 2016 fourth-quarter results, and its stock on Friday is giving a picture of where the rally could 'broaden to,' says Jim Cramer.

Pebble Acquisition Won't Be Material to Fitbit's Results: Deutsche Bank

Pebble Acquisition Won't Be Material to Fitbit's Results: Deutsche Bank

Deutsche Bank downgraded Fitbit to 'hold,' given slower growth in the wearables market.

The Most Admired Corporate Dealmakers in a Record Year

The Most Admired Corporate Dealmakers in a Record Year

In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.

TJX, SBUX, NXPI: Jim Cramer's Views

TJX, SBUX, NXPI: Jim Cramer's Views

Cramer shares his views on taking risk in retail and why some beats are better. TJX, Starbucks and NXP Semi are among the stocks discussed.

Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector

Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector

President-elect Trump's vague healthcare policy has put the $3 trillion industry on edge.

Cramer: Some Beats Are Better Than Others

Cramer: Some Beats Are Better Than Others

There are some good ones today, but for different reasons.

Medtronic Slashes Guidance on Poor Revenue Performance

Medtronic Slashes Guidance on Poor Revenue Performance

Medtronic MDT saw share prices fall sharply Tuesday morning after it reported worse-than-expected earnings for the second quarter of 2017 thanks to slow revenue growth.

Post-Election Investing: Riskier Than You May Think

Post-Election Investing: Riskier Than You May Think

In the week ahead, the markets are likely to pull back as the long-term dangers of Trump's victory start to sink in.

NXPI, AAPL, C: Jim Cramer's Views

NXPI, AAPL, C: Jim Cramer's Views

Cramer shares his views on takeover talks. NXP Semiconductor, Apple and Citigroup are among the stocks discussed.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Technology stocks dominate the bearish ledger this week.

Perrenial Target and Acquirer NuVasive Names New President and COO

Perrenial Target and Acquirer NuVasive Names New President and COO

The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.

Why Boston Scientific Keeps Rising

Why Boston Scientific Keeps Rising

In the last year, shares of Boston Scientific are up almost 50%. Boston Scientific is putting the problems of the past behind it and has a bright future.

TheStreet Quant Rating: A- (Buy)